Promising avelumab plus axitinib data in renal cell carcinoma
The following OncLive interview with leading renal cell carcinoma (RCC) expert, Dr [...]
The following OncLive interview with leading renal cell carcinoma (RCC) expert, Dr [...]
A phase 1 study has evaluated the safety and efficacy [...]
A study investigating the prognostic and predictive value of a [...]
Analysis of the phase 3 CheckMate-214 study has shown that [...]
Results from the KEYNOTE-426 phase 3 study show that the [...]
Results from the JAVELIN Renal 101 phase 3 study to [...]
A clinical trial looking at the combination of avelumab plus [...]
The European Association of Urology (EAU) Renal Cell Cancer Guidelines [...]
A recent article in Annals of Oncology reports new patient-reported outcomes [...]
Today, the National Institute for Health and Care Excellence (NICE) have recommended [...]